Autor/in Augustin, M Melzer, N Thaçi, D 3 Amon, U 2 Bachhuber, T 2 Kasparek, T 2 Kraehn-Senftleben, G 2 Körber, A 2 von Kiedrowski, R 2 Duetting, E 1 Hentschke, C 1 Kneidl, J 1 Mrowietz, U 1 Reich, K 1 Sieder, C 1 Sticherling, M 1 alle zeigenListe einklappen
Secukinumab is effective in treatment of moderate-to-severe plaque psoriasis: real-life effectiveness and safety from the PROSPECT study Thaçi, D Körber, A von Kiedrowski, R Bachhuber, T Melzer, N Kasparek, T Duetting, E 2020 - Forschungsinformationssystem des UKE
Secukinumab treatment of moderate to severe plaque psoriasis in routine clinical care: real-life data of prior and concomitant use of psoriasis treatments from the PROSPECT study Körber, A Thaçi, D von Kiedrowski, R Bachhuber, T Melzer, N Kasparek, T Kraehn-Senftleben, G 2018 - Forschungsinformationssystem des UKE
Secukinumab is superior to fumaric acid esters in treating patients with moderate-to-severe plaque psoriasis who are naive to systemic Treatments: results from the randomized controlled PRIME trial Sticherling, M Mrowietz, U Augustin, M Thaçi, D Melzer, N Hentschke, C Kneidl, J 2017 - Forschungsinformationssystem des UKE